Atara Biotherapeutics, Inc. (ATRA)
NASDAQ·Healthcare·Biotechnology
$4.80
-3.91%
Mkt Cap $40.81M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | $3.37M | $1.64M | -51.17% | -$0.09 | -$0.25 | -177.78% | — | — |
| Q4 2025 Nov 12, 2025 | $700.00K | $3.45M | +393.29% | -$0.83 | -$0.32 | +61.45% | — | — |
| Q3 2025 Aug 11, 2025 | $1.80M | $17.57M | +876.39% | -$0.32 | $0.19 | +159.38% | — | — |
| Q2 2025 May 15, 2025 | $4.30M | $98.15M | +2182.53% | -$3.07 | $3.50 | +214.01% | — | — |
| Q1 2025 Mar 7, 2025 | $20.58M | $32.75M | +59.12% | -$3.82 | -$1.19 | +68.85% | — | — |
| Q4 2024 Nov 12, 2024 | $33.09M | $40.19M | +21.44% | -$3.77 | -$2.93 | +22.28% | — | — |
| Q3 2024 Aug 12, 2024 | $39.99M | $28.64M | -28.38% | -$1.25 | -$3.10 | -148.00% | — | — |
| Q2 2024 May 9, 2024 | $24.69M | $27.36M | +10.80% | -$9.25 | -$5.75 | +37.84% | — | — |
| Q1 2024 Mar 28, 2024 | $11.55M | $4.25M | -63.19% | -$15.25 | -$14.00 | +8.20% | — | — |
| Q4 2023 Nov 1, 2023 | $4.76M | $2.14M | -55.08% | -$15.75 | -$16.50 | -4.76% | — | — |
| Q3 2023 Aug 8, 2023 | $3.77M | $957.00K | -74.62% | -$16.25 | -$17.00 | -4.62% | — | — |
| Q2 2023 May 8, 2023 | $30.68M | $1.23M | -96.00% | -$10.00 | -$18.00 | -80.00% | — | — |
| Q1 2023 Feb 8, 2023 | $34.01M | $221.00K | -99.35% | -$15.25 | -$18.00 | -18.03% | — | — |
| Q4 2022 Nov 8, 2022 | $5.13M | $4.46M | -13.14% | -$19.50 | -$20.50 | -5.13% | — | — |
| Q3 2022 Aug 8, 2022 | $6.84M | $51.58M | +654.35% | -$22.75 | -$7.75 | +65.93% | — | — |
| Q2 2022 May 5, 2022 | $5.79M | $7.31M | +26.38% | -$24.50 | -$21.75 | +11.22% | — | — |
| Q1 2022 Feb 28, 2022 | $31.38M | $7.55M | -75.94% | -$15.00 | -$24.00 | -60.00% | — | — |
| Q4 2021 Nov 4, 2021 | $3.49M | $5.37M | +53.87% | -$23.00 | -$22.50 | +2.17% | — | — |
| Q3 2021 Aug 9, 2021 | $3.84M | $3.87M | +0.78% | -$22.00 | -$22.75 | -3.41% | — | — |
| Q2 2021 May 4, 2021 | $3.78M | $3.55M | -6.12% | -$23.25 | -$21.50 | +7.53% | — | — |